迈普医学：股东凯盈科技、风炎基金拟分别减持不超过0.2237%和0.9964%

Group 1 - Major shareholder Shenzhen Kaiying Technology Co., Ltd. plans to reduce its holdings by no more than 150,000 shares, accounting for 0.2237% of the total share capital [1] - Beijing Fengyan Private Fund Management Co., Ltd. (representing Beijing Fengyan Ruiying No. 3 Private Securities Investment Fund) plans to reduce its holdings by no more than 668,100 shares, accounting for 0.9964% of the total share capital [1] - The reduction period is set for three months starting from 15 trading days after the announcement date [1]